Welcome to our dedicated page for Zepp Health Corporation American depositary shares, each representing sixteen news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation American depositary shares, each representing sixteen stock.
Zepp Health Corporation (NYSE: ZEPP) is a leading global provider of smart wearables and health technology solutions that enable users to maximize their health, fitness, and wellness. Established in 2013 as Huami Corp., the company rebranded to Zepp Health in February 2021 to emphasize its health-centered approach. Zepp Health is renowned for its innovative brands such as Amazfit, Zepp Clarity, and Zepp Aura, which together form a comprehensive ecosystem empowering users to achieve their wellness goals.
Central to Zepp Health's offerings is the proprietary Zepp Digital Health Management Platform, which integrates advanced technologies including Zepp OS, AI chips, biometric sensors, and sophisticated data algorithms. This platform provides 24/7 actionable insights and guidance, supporting users in their everyday health and fitness journeys. To date, Zepp Health has shipped over 200 million units, with its products accessible in more than 90 countries worldwide.
Zepp Health's product portfolio is diverse, featuring smartwatches, fitness bands, and innovative devices like the Amazfit Helio Ring and Amazfit Bip 5 Unity. The company's products are designed to offer a perfect blend of style and cutting-edge technology, appealing to both professional athletes and everyday fitness enthusiasts. Notably, the Amazfit brand has garnered numerous design accolades, including the iF Design Award and the Red Dot Design Award.
Recent achievements highlight Zepp Health's commitment to excellence and community. The company has been actively involved in significant partnerships, such as sponsoring the NN Rotterdam Marathon and the Escape from Alcatraz Triathlon. Through these partnerships, Zepp Health not only promotes its high-performance wearables but also supports athletic communities worldwide.
Financially, Zepp Health reported revenues of US$39.8 million for the first quarter of 2024, with a gross margin of 36.8%. Despite a challenging market, the company's self-branded products have shown robust performance, contributing significantly to its revenue. Looking forward, Zepp Health continues to expand its product offerings and invest in strategic marketing initiatives, ensuring sustained growth and innovation.
Zepp Health's commitment to advancing health technology is further exemplified by its partnership with LiveX AI to enhance customer experiences on the Amazfit website. This collaboration utilizes AI to provide personalized and efficient customer support, setting a new standard in the industry.
For more information about Zepp Health Corporation and its innovative health technology solutions, visit www.zepp.com.
Zepp Health Corporation (NYSE: ZEPP) filed its annual report on Form 20-F for the fiscal year ending December 31, 2022, with the U.S. Securities and Exchange Commission. The report details the company’s performance as a leader in cloud-based healthcare services and smart wearable technology. The 2022 filing highlights that Zepp Health shipped 20 million units in smart health devices, reinforcing its position as a global leader in the sector. Shareholders can request free hardcopies of the report by contacting the company directly.
Founded in 2013, Zepp Health was known as Huami Corp. until its name change on February 25, 2021. The company continues to innovate with AI chips and biometric sensors aimed at enhancing health technology.
Zepp Health Corporation (NYSE: ZEPP) reported Q4 2022 revenues of RMB1.1 billion (US$155.4 million), a 35.5% decrease from Q4 2021, primarily due to a 65.5% drop in Mi Band sales. The company recorded a net loss of RMB75.5 million, contrasting with a net income of RMB36.3 million a year earlier. However, self-branded products saw a 28.5% quarter-over-quarter revenue growth and accounted for 77.4% of total revenues. Gross margin improved to 20.7%, driven by optimized product offerings. Looking ahead, Zepp anticipates Q1 2023 revenues between RMB0.60 billion and RMB0.75 billion, reflecting market uncertainties and sales conditions.
Amazfit, a brand owned by Zepp Health (NYSE: ZEPP), launched the Amazfit T-Rex Ultra, a premium outdoor GPS smartwatch designed for extreme conditions. This watch features a rugged design with 316L stainless steel, capable of operating in temperatures as low as -30℃ and maximizing visibility with a 1,000 nits AMOLED display. It boasts enhanced GPS tracking, a battery life of up to 20 days, and can support over 160 sports modes, including unique activities like freediving and skydiving. Priced from $399.99, the T-Rex Ultra targets adventure enthusiasts seeking advanced training features and eco-friendly design.
Amazfit, a prominent smart wearables brand under Zepp Health (NYSE: ZEPP), has launched the Amazfit GTR Mini, a compact smartwatch featuring a 42mm design, 14-day battery life, and over 120 sports modes. The sleek device weighs only 24.6g and includes a 1.28-inch HD AMOLED display. Notable features include enhanced GPS tracking with five satellite systems, automatic sport recognition, and continuous health monitoring. Priced at $119.99 in the US and €129.90 in EMEA, the Amazfit GTR Mini is now available at Amazfit stores. This release reinforces Amazfit's commitment to health and fitness technology.
Zepp Health Corporation (NYSE: ZEPP), a leader in smart wearable technology, will report its fourth quarter and full year 2022 unaudited financial results on March 21, 2023, before market opening. A conference call is scheduled for 8:00 a.m. ET on the same day. Participants can access the call via US toll-free number +1-888-346-8982 or international number +1-412-902-4272. The live webcast and archived version will also be available on the company’s investor relations website. This announcement highlights Zepp Health's ongoing commitment to integrate health with technology and its position as a developer of health and fitness devices.
Zepp Health Corporation (NYSE: ZEPP) has announced it will report its third quarter 2022 unaudited financial results before market open on November 21, 2022. Management will conduct a conference call at 7:30 a.m. ET on the same day, accessible via various dialing options for US and international listeners. Additionally, a live and archived webcast will be available on their investor relations website. Zepp Health, previously known as Huami Corp., focuses on integrating health with technology through smart wearable devices and data analytics.
Zepp Health Corporation (NYSE: ZEPP) is sponsoring Cal Hacks, the largest collegiate hackathon, from October 14-16, 2022, at UC Berkeley. Participants can win cash prizes and Amazfit smartwatches by creating innovative watch faces and apps using Zepp OS APIs. The event, aimed at empowering technology for social good, is expected to attract talented students globally. Applications are open until September 30, 2022, and participation is free for accepted applicants. Zepp Health emphasizes community building through its developer tools, driving inclusivity in technology innovation.
Amazfit, a leading smart wearables brand under Zepp Health (NYSE: ZEPP), has partnered with adidas Runtastic to enhance its health and fitness offerings. This collaboration aims to provide advanced workout tracking and data sharing for athletes globally. The Zepp App will enable users to sync various health metrics with the adidas Running app, improving fitness monitoring and reporting. The partnership is set to launch in Q4 2022, initially compatible with the Amazfit GTR 4 and GTS 4 smartwatches. This initiative highlights both brands' commitment to promoting healthier lifestyles.
Zepp Health Corporation (NYSE: ZEPP) reported Q2 2022 revenues of RMB1.1 billion (US$165.5 million), down 39.6% year-over-year but up 46.4% from Q1. The company faced challenges from a late product launch due to chip shortages and a decline in units shipped, which decreased 45.2% year-over-year to 6.3 million. Net loss was RMB106.9 million, compared to net income of RMB92.6 million in Q2 2021. The CFO highlighted improvements in revenue and cost control, while the outlook for Q3 2022 projects revenues between RMB1.2 billion and RMB1.5 billion.
FAQ
What is the current stock price of Zepp Health Corporation American depositary shares, each representing sixteen (ZEPP)?
What is the market cap of Zepp Health Corporation American depositary shares, each representing sixteen (ZEPP)?
What is Zepp Health Corporation?
When was Zepp Health founded?
What products does Zepp Health offer?
What technology powers Zepp Health's products?
How many units has Zepp Health shipped to date?
In how many countries are Zepp Health's products available?
What recent partnerships has Zepp Health formed?
What financial performance did Zepp Health report for Q1 2024?
What distinguishes Zepp Health's customer support?